Amneal Pharmaceuticals, Inc.

NYSE:AMRX

7.78 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Omzet 702.468701.78659.191616.981620.04599.046557.54609.759545.557559.355497.633536.896528.593535.075493.105510.034519.294464.662498.533397.328378.283404.642446.12497.528476.487413.787275.189293.369254.733259.871225.681298.576
Kosten van de omzet 432.91451.833421.131427.154387.509379.025379.354394.371351.327358.836323.062370.494330.082322.577301.543342.962385.709320.425315.034287.094323.849299.393363.04304.12276.382235.492130.594141.953119.72136.138115.832121.926
Brutowinst 269.558249.947238.06189.827232.531220.021178.186215.388194.23200.519174.571166.402198.511212.498191.562167.072133.585144.237183.499110.23454.434105.24983.08193.408200.105178.295144.595151.416135.013123.733109.849176.65
Brutowinstmarge 0.3840.3560.3610.3080.3750.3670.320.3530.3560.3580.3510.310.3760.3970.3880.3280.2570.310.3680.2770.1440.260.1860.3890.420.4310.5250.5160.530.4760.4870.592
Onderzoek- en ontwikkelingskosten 61.09737.09639.29846.56442.26138.61940.33443.26951.64651.56953.56253.01650.55454.22951.76457.16146.65349.12237.64953.02540.71150.52758.02460.53447.454.38248.78546.22648.01652.1139.41943.513
Algemene en administratieve kosten 0000000000000000000151.717067.28184.43671.23678.07553.00325.12126.96627.4426.93800
Verkoop- en marketingkosten 0000000000000000000-77.633000000000000
Verkoop-, algemene en administratieve kosten 118.692116.462112.595109.003113.006105.57102.096102.158100.07198.80698.66597.22491.39786.15790.72684.68783.1280.94477.97674.08463.79767.28184.43671.23678.07553.00325.12126.96627.4426.93827.70231.126
Overige kosten 04.364.0720.4111.1570.012-1.224-1.465-1.326.9392.1226.6333.8714.0320.7940.4880.8980.5710.633-0.1970.4460.1491.1072.123-1.0140.7910.9480.024-0.093-0.07800
Bedrijfskosten 178.782167.002151.893155.567155.34144.202141.206143.962150.397149.2152.227150.24141.951140.386142.49141.848129.773130.066115.625127.109104.508117.808142.46131.77125.475107.38573.90673.19275.45679.04852.424100.794
Bedrijfsresultaat 88.80995.47-10.74614.19375.64880.08434.44974.19844.353-198.61823.30511.17528.51567.11945.90720.1782.43510.75157.791-23.135-112.274-18.913-94.3623.2874.555-181.06263.55479.01978.75344.60342.72892.297
Bedrijfsresultaat ratio 0.1260.136-0.0160.0230.1220.1340.0620.1220.081-0.3550.0470.0210.0540.1250.0930.040.0050.0230.116-0.058-0.297-0.047-0.2120.0470.156-0.4380.2310.2690.3090.1720.1890.309
Totaal overige inkomsten en kosten netto -73.386-75.065-64.776-97.654-52.691-50.424-43.875-43.687-42.173-34.113-33.226-27.494-30.558-32.295-31.003-25.655-24.324-32.509-44.447-33.976138.55-37.314-38.82-38.086-51.981-81.444-11.538-16.944-52.369-5.0030.536-36.513
Inkomen voor belasting 15.42320.405-75.522-83.46122.95729.66-9.426-7.6552.18-232.731-9.921-16.319-2.04334.82414.904-5.477-21.889-21.75813.344-57.11126.276-56.227-133.18-14.80622.574-262.50652.01662.07526.38439.643.26455.959
Inkomen voor belasting ratio 0.0220.029-0.115-0.1350.0370.05-0.017-0.0130.004-0.416-0.02-0.03-0.0040.0650.03-0.011-0.042-0.0470.027-0.1440.069-0.139-0.299-0.030.047-0.6340.1890.2120.1040.1520.1920.187
Belastingkosten 3.6663.6186.1569.883-2.076-0.0230.668-1.7974.577.35-3.4614.144.0492.6480.3591.4850.1442.186-108.1737.792389.668-5.701-8.4285.5245.109-12.4160.364-0.119-0.7381.8521.0031.55
Nettowinst -0.1565.994-91.643-98.6499.68211.917-10.094-5.858-2.39-120.808-6.46-6.377-4.23714.5326.706-3.037-8.975-11.996115.067-32.128-265.006-16.902-47.881-8.7686.952-219.44551.53561.56926.7837.44642.26153.898
Nettowinstmarge -00.009-0.139-0.160.0160.02-0.018-0.01-0.004-0.216-0.013-0.012-0.0080.0270.014-0.006-0.017-0.0260.231-0.081-0.701-0.042-0.107-0.0180.015-0.530.1870.210.1050.1440.1870.181
WPA (Winst Per Aandeel) 0.0380.02-0.3-0.40.060.08-0.066-0.039-0.016-0.8-0.043-0.043-0.0280.10.05-0.021-0.061-0.0810.78-0.23-2.03-0.13-0.37-0.0690.05-1.730.450.540.230.3300.29
Verwaterde WPA 0.0380.02-0.3-0.40.060.08-0.066-0.039-0.016-0.8-0.043-0.043-0.0280.10.04-0.021-0.061-0.0810.78-0.23-2.03-0.13-0.37-0.0690.05-1.730.450.540.230.3300.29
EBITDA 146.763151.96145.709138.325134.397132.93106.13137.807106.141-137.41280.15999.349117.434128.6104.62185.09795.53573.002127.41336.02159.41638.365-41.03175.567128.697-181.06285.44115.06671.51544.60753.328102.011
EBITDA ratio 0.2090.204-0.0160.0820.2190.2220.1770.2220.2040.2110.1650.1560.1140.2480.2140.050.1230.1570.2540.094-0.1310.095-0.0210.1280.2450.2510.3140.310.280.1720.2360.342